Investing Profile

Florent Gros

InvestorVC
Venture Partner at Earlybird Venture Capital
earlybird.comAntwerp, Belgium
Photo of Florent Gros, Venture Partner at Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
20
€350m
CompanyStageDateRound SizeTotal Raised
ImCheck Therapeutics
Series CJun 2022$100M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Raphael Wisniewski (Andera Partners), Michael Baran (Pfizer Venture Investments), Rémi Droller (Kurma Partners), Dr. Regina Hodits (Wellington Partners), Vincent Brichard
Oculis
Series CMay 2021$57M
Series BJan 2018$21M
$170M
Co-investors: Rob Hopfner (Pivotal bioVenture Partners), Lionel Carnot (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Anokion
Series BSep 2019$40M
Series AMay 2014$38M
$78M
Co-investors: Tom Woiwode (Versant Ventures), Jack Nielsen (Vivo Capital)
Binx Health
Series DJan 2017$35M
Series CJan 2015$20M
Series BApr 2014$28M
Series BJul 2011$27M
$210M
Co-investors: Matthew Rizzo (OrbiMed), Joachim Rothe (EQT Life Sciences)
Myopowers Medical Technologies
Series CJun 2015$5M
Series BJul 2011$16M
$21M
Merus
Series CApr 2015$79M
Series BOct 2013$42M
Series BJan 2010$30M
$150M
Co-investors: John de Koning (EQT Life Sciences), Lionel Carnot (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)
Opsona
Series COct 2013$4M
Series CApr 2013$43M
Series BJun 2009$5M
$52M
Immune Targeting Systems
Series AMar 2010$13M
Series AJul 2007$7M
$20M
Co-investors: Marten Steen (HealthCap)
Managing Director Novartis Venture Fund2001 - 2019